Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic Acid for Frequent Cyanotic Breath Holding Spells
NCT04482764Phase 1Completed
- Sponsor
- Assiut University
- Start
- Jan 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of valproic acid in breath-holding spells, sponsored by Assiut University. Primary endpoint: Frequency of spells after starting treatment with valproic acid at 6 months. Started Jan 2017; status: completed.
02
Drugs
valproic acid
03
Conditions
breath-holding spells
Beyond the preview
Go deeper on NCT04482764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04482764.